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Myeloid-derived suppressor cells (MDSCs) cause paraneoplastic leukemoid reac-
tions and facilitate tumor cell metastasis. However, the interaction of MDSCs
with tumor cells in live tissue has not been adequately visualized. To accomplish
this task, we developed an intravital imaging protocol to observe metastasized
tumor cells in mouse lungs. For visualization of the activation of MDSCs, bone
marrow cells derived from transgenic mice expressing a F€orster resonance energy
transfer biosensor for ERK were implanted into host mice. Under a two-photon
excitation microscope, numerous polymorphonuclear cells (PMNs) were found to
infiltrate the lungs of tumor-bearing mice in which 4T1 mammary tumor cells
were implanted into the footpads. By F€orster resonance energy transfer imaging,
we found ERK activation in PMNs around the 4T1 tumor emboli in the lungs.
Because antibody array analysis implied the involvement of osteopontin (OPN) in
the metastasis of 4T1 cells, we further analyzed the effect of OPN knockdown.
The OPN knockdown in 4T1 cells did not affect the cell growth, but markedly
suppressed lung metastasis of 4T1 cells and ERK activation in PMNs in the lung.
Intravenous injection of recombinant OPN restored the lung metastasis of OPN-
deficient 4T1 cells, suggesting that OPN functioned in a paracrine manner. It has
been reported that ERK activation of neutrophils causes NETosis and that PMNs
promote metastasis of tumor cells by NETosis. In agreement with previous
reports, the NETosis inhibitor DNase I inhibited lung metastasis of 4T1 cells. These
observations suggest that OPN promotes metastasis of 4T1 cells by activating
PMNs and inducing NETosis.
T umor microenvironments contribute to the initiation, pro-gression, and metastasis of tumor cells.(1) Myeloid-derived
suppressor cells, which are a heterogeneous cell population of
monocytic and granulocytic immature cells,(2) cause paraneo-
plastic leukemoid reactions and facilitate tumor cell metasta-
sis.(3) Growth of 4T1 tumor cells, which have been
extensively used as a metastasis model of human metastatic
breast cancer,(4) also accompanies paraneoplastic leukemoid
reactions in a manner dependent on cytokines and ECM pro-
teins, including granulocyte-colony stimulating factor, mono-
cyte chemoattractant protein 1/C-C motif chemokine ligand 2
and preosteoblast EGF-like repeat protein with MAM
domain.(5–7)
Osteopontin, also known as secreted phosphoprotein 1, is
another extracellular protein that exerts a pleiotropic effect on
tumor growth.(8) The functional mechanisms linked to the
tumor-promoting activities of OPN include increased survival
of tumor cells, enhanced invasion, and angiogenesis.(9) More-
over, OPN also induces systemic tumor-promoting effects such
as facilitation of the growth of indolent tumors and recruitment
of bone marrow-derived cells.(10)
The advent of intravital imaging by two-photon microscopy
has greatly accelerated our understanding of the dynamic
aspect of the metastatic process: cells exit the primary tumor,
invade the local tissue, intravasate, extravasate, and colonize at
remote organs.(11) However, intravital imaging of lung, the pri-
mary target of tumor metastasis, has not been as easy as that
of other organs due to the motion artifacts caused by breath-
ing.(12) The recent invention of the vacuum-stabilized imaging
window has greatly alleviated the motion artifacts of the lung
and permitted live imaging of this organ.(13,14) For example,
Headley et al.(15) visualized the phagocytosis of the frag-
mented cell body of cancer cells by residential macrophages of
the lung.
The recent application of FRET biosensors to intravital
imaging has opened a new field of research, which visualizes
the spatiotemporal dynamics of signaling molecule activities in
a physiological context. For example, the effects of anticancer
drugs have been visualized in tumors of live mice(16–18) and
the timing of neutrophil activation was captured during
extravasation in an inflamed tissue.(19) Here, by using trans-
genic mice expressing the FRET biosensor for the ERK
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MAPK, we show that polymorphonuclear leukocytes in tumor-
bearing mice are activated by direct interaction with 4T1
tumor cell emboli in the pulmonary capillary. Osteopontin has
been found to be indispensable not only for the activation of
PMNs but also colonization of the tumor cells.
Materials and Methods
Plasmids. pCX4-derived lentiviral expression vectors were
provided by Tsuyoshi Akagi.(20) Lentiviruses were produced
by using Lenti-X 293T cells according to the manufacturer’s
protocol (TaKaRa Bio, Shiga, Japan). The pPB piggyBac
transposon vector and pCMV-mPBase (neo-) encoding the pig-
gyBac transposase were provided by Kosuke Yusa and Allan
Bradley of the Welcome Trust Sanger Institute (Cambridge,
UK).(21) The shRNA sequences inserted into the pLKO.1 TRC
lentivirus vector (Addgene, Cambridge, MA, USA) are shown
in Table S1. As a negative control, a scramble shRNA (scr)
(plasmid #1864; Addgene) was used.
Mammary tumor cell culture. 4T1 mammary tumor cells
were purchased from ATCC (Manassas, VA, USA) and main-
tained on a collagen-coated dish (AGC Techno Glass, Tokyo,
Japan) in RPMI-1640 medium (Thermo Fisher Scientific,
Waltham, MA, USA) containing 10% FBS (Sigma-Aldrich,
St. Louis, MO, USA) and 1% penicillin–streptomycin (Naca-
lai Tesque, Kyoto, Japan) at 37°C in a humidified atmosphere
containing 5% CO2. A BindShut II dish (AGC Techno Glass)
was used for suspension culture. For establishment of 4T1
cell lines expressing iRFP, 4T1 cells were infected with the
lentivirus produced from pCX4bsr-iRFP. After blasticidin S
selection at 10 lg/mL for 1 week, the bright cell population
was collected by FACS (FACSAria II; BD Biosciences,
Franklin Lakes, NJ, USA) and subjected to single cell clon-
ing. For the expression of tdTomato, piggyBac transposon
plasmids encoding the tdTomato gene (pPBbsr2-tdTomato)
and pCMV-mPBase were cotransfected into 4T1 cells by
using Lipofectamine 3000 (Thermo Fisher Scientific). After
blasticidin S selection (10 lg/mL) for 1 week, the bright cell
population was collected by FACS. For knockdown experi-
ments, 4T1 cells were infected with lentiviruses encoding
shRNAs (Table S1) or scramble control. After puromycin
selection for 1 week, knockdown efficiency was confirmed by
immunoblotting.
Antibodies and reagents. The following primary and sec-
ondary antibodies were used for immunoblotting: anti-mouse
OPN rabbit polyclonal antibody (IB1397; Immuno-Biological
Laboratories, Gunma, Japan), anti-a-tubulin (DM1A) mouse
mAb (Millipore, Billerica, MA, USA), IRDye 680 goat anti-
mouse IgG and IRDye 800CW goat anti-rabbit (LI-COR Bio-
sciences, Lincoln, NE, USA). Anti-CD44 (GTX15834) was
purchased from GeneTex (Irvine, CA, USA). Anti-CD51
(104108), anti-CD61 (104310), anti-CD29 (102209), and rat or
hamster IgG were purchased from BioLegend (San Diego, CA,
USA). Phycoerythrin-labeled anti-Gr-1 and allophycocyanin-
labeled anti-Ly6G (1A8) were purchased from BioLegend.
Collagen type C was purchased from Nitta Gelatin (Osaka,
Japan). Blasticidin S and puromycin were purchased from Invi-
voGen (San Diego, CA, USA). Geltrex and Qtracker 655 were
purchased from Thermo Fisher Scientific. DNase I was pur-
chased from Roche Diagnostics (Basel, Switzerland).
PD0325901 was purchased from Wako (Osaka, Japan).
Immunoblotting. 4T1 cells were lysed in 19 SDS sample
buffer (62.5 mM Tris-HCl [pH 6.8], 12% glycerol, 2% SDS,
0.04% bromophenol blue, and 5% 2-mercaptoethanol). After
sonication, the samples were loaded on precast 5–20% SDS-
PAGE gels (SuperSep Ace; Wako) and transferred to PVDF
membranes (Millipore). After blocking with Odyssey blocking
buffer (LI-COR Biosciences) diluted 1:2 in TBS-T for 30 min,
the membranes were incubated with primary antibodies diluted
in Can Get Signal (Toyobo, Osaka, Japan), followed by sec-
ondary antibodies diluted in TBS-T. Proteins were detected by
an Odyssey Infrared Imaging System (LI-COR Biosciences)
and analyzed by using the Odyssey imaging software.
Immunohistochemistry. Mouse lungs were fixed by intratra-
cheal administration of 4% paraformaldehyde in PBS. Paraffin-
embedded tissues were sectioned with 3-lm thickness and
stained with anti-phospho-ERK (#4370; Cell Signaling Tech-
nology, Danvers, MA, USA), anti-Gr-1 (RB6-8C5; BioLe-
gend), and anti-OPN (IBL, Fujioka, Gunma, Japan) antibodies.
Antibodies were visualized with 3,30-diaminobenzidine
(Dojindo, Kumamoto, Japan). Frozen sections with 6-lm thick-
ness were stained with anti-phospho-ERK, anti-Gr-1, and anti-
citrullinated histone H3 (ab5103; Abcam) antibodies and visu-
alized with Alexa Fluor 488-conjugated goat anti-rabbit IgG
(Thermo Fisher Scientific). Cell nuclei were stained with DAPI
(Sigma-Aldrich).
Antibody array. 4T1 cells were cultured in RPMI-1640 for
24 h to prepare the conditioned medium. Blood samples were
collected from the postcaval vein of tumor-bearing mice at day
30 or healthy mice. Plasma was collected by centrifugation at
1500 g for 10 min in a heparin-coated tube. The conditioned
medium and plasma were subjected to Mouse Cytokine Array
4 (AAM-CYT-4-8; Raybiotech, Norcross, GA, USA) or
Inflammation Antibody Array 1 (AAM-INF-1-8; Raybiotech)
according to the manufacturer’s protocol for the Odyssey
Infrared Imaging System (LI-COR Biosciences). The mean
spot density was measured by using the Odyssey software
(LI-COR Biosciences), and mean values above the reference
value (mean density of the negative control spots) were charted
on a graph using Excel 2010 (Microsoft, Redmond, WA, USA).
Cell growth assay. The iRFP-expressing cell lines were dou-
ble-diluted from 1 9 105/well to 1 9 102/well and plated onto
collagen-coated 96-well glass-bottom plates (#4860-010; AGC
Techno Glass) in RPMI-1640 medium containing 10% FBS.
Fluorescence at 700 nm was measured by an Odyssey Infrared
Imaging System (LI-COR Biosciences) under the following
conditions: resolution = 21 lm, quality = medium, inten-
sity = 5.0 (700 nm), and focus offset = 0.5 mm. Three wells
in which the fluorescence was correlated linearly to the num-
ber of cells were used for the analysis (n = 3).
Anchorage-independent sphere formation assay. The iRFP-
expressing cell lines were maintained by shaking at 70 rpm in
a humidified CO2 incubator essentially as described in previ-
ous studies.(22–24) Cells were dissociated with Accutase
(Sigma-Aldrich) and transferred to non-coated 6-well plates
(#1810-006; AGC Techno Glass) in 2.25 mL serum-free
RPMI-1640 medium at 5 9 105 cells/well. After the addition
of blocking antibodies at 2 lg/mL, cells were cultured on the
shaker. Cell growth was measured with the Odyssey Infrared
Imaging System as described above, except that the focus off-
set was set to 4 mm. Cell spheres were quantified by Meta-
morph software (Molecular Devices, Sunnyvale, CA, USA). In
some experiments, cell spheres were collected by centrifuga-
tion at 300 g for 5 min, and trypsinized for 5 min at room
temperature. Cells were then resuspended in serum-containing
PBS and counted by a Countess automated cell counter
(Thermo Fisher Scientific) according to the manufacturer’s
protocol. In the coculture experiment, iRFP-labeled 4T1 cells
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expressing shRNA against OPN (sh870) were cultured in the
first well (5 9 105/well). In the second well, iRFP-labeled 4T1
cells expressing sh870 (2.5 9 105/well) and non-labeled 4T1
cells expressing the scr RNA (2.5 9 105/well) were cocul-
tured. After 24 h, the number of cell spheres was counted.
Recombinant OPN purification. Mouse OPN cDNA was pur-
chased from Sino Biological (MG50116M; Beijing, China).
The 129 histidine-tag was inserted after the signal peptide
sequence by PCR with the following primer set: forward,
50-ctcgaggccaccatgaggctgcagttctcctggctgaattctgagggactaactacga
ccatgagattggcagtgatttg-30; and reverse, 50-gcggccgcctagtgatggt
gatggtgatggtgatggtgatggtgatgtggtccctggaacaggacttccagtccggagtt
gacctcagaagatgaactc-30. The PCR fragment was inserted into
the pPBbsr expression vector. The resulting plasmid pPBbsr2-
OPN-12xHis was cotransfected with the piggyBac transposase
expression vector into Lenti-X 293T cells (TaKaRa Bio) with
293fectin (Thermo Fisher Scientific). The conditioned medium
from 10 culture dishes was collected and centrifuged at 360 g
95 min to remove cell debris. After the equilibration with
PBS and 3 h of mixing with conditioned medium, TALON
resin (TaKaRa Bio) was washed three times with wash buffer
(50 mM NaH2PO4, 300 mM NaCl, and 10 mM imidazole [pH
7.0]) and mixed with elution buffer (50 mM NaH2PO4,
300 mM NaCl, and 500 mM imidazole [pH 7.0]) to elute the
OPN-12xHis fusion protein. The eluate was dialyzed with 29
PBS by using Slide-A-Lyzer Dialysis Cassettes (MWCO 2K;
Thermo Fisher Scientific). The purity and amount of purified
OPN were checked by immunoblotting with OPN antibody
and Coomassie Brilliant Blue staining (Bio-Rad, Hercules, CA,
USA). Commercially available recombinant mouse OPN
(R&D Systems, Minneapolis, MN, USA) was used as a refer-
ence protein.
Metastasis model. BALB/c mice were purchased from Japan
SLC (Shizuoka, Japan) and housed in a specific pathogen-free
facility, and received unrestricted access to normal chow and
drinking water. Mice (7–16 weeks old) were inoculated with
1 9 106 4T1 cells suspended in 50 lL PBS containing 50%
Geltrex at the footpad.(25,26) After 2–4 weeks, the local tumor
volume was calculated by the following formula: tumor vol-
ume (mm3) = length 9 width 9 height 9 0.523. Lung meta-
static foci of iRFP-expressing cells were visualized by an
Odyssey Infrared Imaging System (LI-COR Biosciences) under
the following conditions: resolution = 21 lm, qual-
ity = medium, intensity = 5.0 (700 nm)/5.0 (800 nm), and
focus offset = 0.5 mm. The number of foci was obtained by
MetaMorph software (Molecular Devices) with an inclusive
threshold ≤200 for lung area and an inclusive threshold ≤2500
and size ≥10 for foci. In some experiments, the tumor-bearing
mice or healthy control mice were inoculated i.v. with 4T1
cells that were prepared as follows: 4T1 cells maintained on
collagen-coated dishes were harvested by Accutase, collected
by centrifugation at 300 g for 5 min and cultured in RPMI-
1640 medium with 10% FBS on non-coated BindShut
II dishes for 8–10 h. After the removal of cell spheres with a
35-lm cell strainer (#352235; BD Biosciences), the cells were
counted and 1 9 105 cells were injected from the tail vein. In
the experiment with recombinant OPN injection, sh870-expres-
sing 4T1 cells were injected into the footpads of BALB/c
mice. Two weeks later, recombinant OPN protein (8.4 lg/
mouse) was injected i.v. into tumor-bearing mice for 5 days
prior to the injection of iRFP-labeled sh870-expressing 4T1
cells (1 9 105). Three days later, metastatic foci in the lung
were counted by an Odyssey Infrared Imaging System
(LI-COR Biosciences). In the experiment with DNase I
injection, scr-expressing 4T1 cells were injected into the foot-
pads of BALB/c mice. Two weeks later, DNase I (2000 U) in
PBS was given i.v. to tumor-bearing mice after the i.v. injec-
tion of iRFP-labeled scr-expressing 4T1 cells (1 9 105). Three
days later, metastatic foci in the lung were counted by an
Odyssey Infrared Imaging System. The animal protocols were
reviewed and approved by the Animal Care and Use Commit-
tee of Kyoto University Graduate School of Medicine (No.
15064; Kyoto, Japan).
Bone marrow transplantation. Transgenic mice expressing
the FRET biosensor for ERK activity have been reported pre-
viously.(22) The transgenic mice were back-crossed for more
than six generations to BALB/c mice. Bone marrow transplan-
tation was carried out according to the general protocol with
some modifications.(27) Briefly, bone marrow cells were har-
vested from the femurs and tibias of the transgenic mice. Red
blood cells were lysed with red blood cell lysis buffer (0.75%
NH4Cl, 0.017 M Tris-HCl [pH 7.65], and 1 lM EDTA).
Recipient mice were irradiated with 10-Gy gamma rays and
received 6 9 106 bone marrow cells through the tail vain.
Bone marrow-transplanted mice were housed in a specific
pathogen-free facility and received drinking water containing
0.5 mg/mL enrofloxacin (pH 3.0; Tokyo Chemical Industry,
Tokyo, Japan) for 1 month before experiments.
Intravital lung imaging by two-photon excitation microscopy.
Mice were anesthetized by 1.0–1.5% isoflurane (Wako) inhala-
tion and placed on an electric heating pad (ThermoPlate;
Tokai-Hit, Shizuoka, Japan) maintained at 37°C. Isoflurane
was supplied through a tracheostomy tube (Surflo indwelling
catheter 22G; Terumo, Tokyo, Japan) connected to an artificial
respirator (MK-V100; Muromachi Kikai, Tokyo, Japan) under
the following respirator conditions: 55 b.p.m., 35 mL/min, and
an inspiratory/expiratory ratio of 3:2. For stabilizing the
exposed lung, a custom-made vacuum-stabilized imaging win-
dow was placed over the lung. Mice were observed with an
FV1200MPE-BX61WI upright microscope (Olympus, Tokyo,
Japan) equipped with a 25 9 /1.05 water-immersion objective
lens (XLPLN 25XW-MP; Olympus), which was connected to
an InSight DeepSee laser (Spectra Physics, Mountain View,
CA, USA). Images (512 9 512 pixels) were scanned at 2 ls/
pixel with 1.59 digital zoom. The excitation wavelength for
cyan fluorescent protein was 840 nm. We used an IR-cut filter,
BA685RIF-3, two dichroic mirrors, DM505 and DM570, and
three emission filters, BA460-500 (Olympus) for cyan fluores-
cent protein, BA520-560 (Olympus) for yellow fluorescent pro-
tein, and 645/60 (Chroma Technology, Bellows Falls, VT,
USA) for tdTomato fluorescence. Acquired images were ana-
lyzed with MetaMorph software (Molecular Devices). If neces-
sary, antibodies, cells, or recombinant proteins were injected
from the tail vein.
Statistical analysis. P-values for normal distributed data were
calculated with Student’s t-test for the evaluation of statisti-
cally significant differences. For multiple groups, ANOVA was
used. Data analysis was carried out using Excel 2010 (Micro-
soft) or Prism software (GraphPad Software, La Jolla, CA,
USA). Significance is shown as *P < 0.05, **P < 0.01, and
***P < 0.001.
Results
Intravital FRET imaging of lungs of tumor-bearing mice. To
gain insight into the mechanism of tumor metastasis, we
undertook intravital FRET imaging of the lung. Motion arti-
facts caused by the animal’s breathing were minimized by
© 2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd
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using a vacuum-stabilized imaging window (Fig. 1a,b). BALB/
c mice expressing a FRET biosensor for ERK MAPK, called
FRET mice hereafter, were used to monitor cell activation.
The ERK biosensor localizes at the cytoplasm and allows us to
distinguish nuclear shapes. Monitoring was carried out up to a
depth of 60 lm with a resolution sufficient to distinguish
Ly6G/Gr-1-positive PMNs based on the nuclear shape
(Figs 1c,d,S1). The morphology and the Ly6G/Gr-1 positivity
suggest that these PMNs are granulocytic MDSCs.(2) For con-
sistency, we hereafter refer to these lung-infiltrating cells as
PMNs.
The 4T1 mammary tumor cells were inoculated into syn-
geneic transgenic FRET mice at the footpad. Neutrophil infil-
tration into the lungs was observed within 1 week, followed
by remarkable hepatosplenomegaly within 3 weeks (Fig. 1e).
Prominent infiltration of PMNs was also observed in the lung
(Fig. 1f, Movie S1). During the time-lapse observation, occa-
sional ERK activation in PMNs was observed (Figs 1f,S2,
arrowheads). This observation implies that ERK activation in
PMNs may play a role in the colonization of tumor cells in
the lung. We attempted to visualize ERK activation in PMNs
in paraffin-fixed lungs by using an anti-phospho-ERK antibody
(Fig. S3). However, we failed to show PMNs with high ERK
activity convincingly, probably due to low sensitivity of
immunohistochemistry.
Osteopontin required for growth of 4T1 mammary tumor cells
in suspension culture. To understand the mechanism of PMN
activation by 4T1 tumor cells, we searched pro-metastatic
Fig. 1. Intravital F€orster resonance energy transfer
(FRET) imaging of lung metastasis in mouse by two-
photon excitation microscopy. (a) Layout of the
intravital imaging system for the mouse lung. An
anesthetized FRET mouse for ERK was placed on an
electric heating pad and set under a custom-made,
vacuum-stabilized imaging window to minimize the
motion artifacts caused by breathing. (b) The top
and back view of the vacuum-stabilized imaging
window. The diameter of the window area is
4 mm. (c) Cyan fluorescent protein fluorescence
image of the lung of a FRET mouse, into which
6 lg phycoerythrin (PE)-labeled anti-Gr-1 antibody
was injected i.v. (d) Magnified images of the boxed
region in (c). The PE image of the same region is
also shown. Note that the polymorphonuclear cells
(PMNs) are stained with PE-labeled anti-Gr-1
antibody. (e) Image of hepatosplenomegaly
3 weeks after tumor inoculation at the footpad. (f)
Bone marrow cells of a FRET mouse for ERK were
transferred to a recipient BALB/c mouse. One
month after bone marrow transplantation, 4T1 cells
were inoculated at the footpad. The lung was
observed on the day of tumor cell inoculation (day
0) and day 7. Yellow fluorescent protein images
(left) and FRET/cyan fluorescent protein images for
ERK activity (right) are shown. Of note, ERK
activation is observed in some PMNs (arrowheads).
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molecules secreted by 4T1 tumor cells by using a Mouse Cyto-
kine Array 4 and Inflammation Array 1 (Figs 2a,S4). In addi-
tion to known pro-metastatic cytokines such as granulocyte-
colony stimulating factor, monocyte chemoattractant protein-1,
and MMP-3, we found that OPN was increased in the condi-
tioned medium of 4T1 cells. Because OPN has been reported
to recruit neutrophils and facilitate metastasis of various
tumors, in the following study we focused on the contribution
of OPN to the metastasis of 4T1 cells. First, we knocked down
OPN by shRNAs in 4T1 cells. In agreement with a previous
report,(10) shRNAs against OPN did not alter the cell growth
or morphology of the 4T1 cells that grew on culture dishes
(Fig. 2b–d). However, in suspension culture, expression of
shRNAs against OPN markedly inhibited sphere formation
(Fig. 2e–g) and replication of 4T1 cells (Fig. 2h,i). Sphere for-
mation with OPN-depleted cells was rescued by the addition
of non-fluorescent cells with scr shRNA (Fig. 2j), indicating
that OPN could function in trans. To examine which OPN
receptor mediates the sphere formation of 4T1 cells, we exam-
ined the effect of antibodies against several potential OPN
receptors: CD44, CD51 (integrin av), CD61 (integrin b3), and
CD29 (integrin b1). Among them, only anti-CD44 inhibited
the sphere formation of 4T1 cells (Fig. 2k). In agreement with
this observation, shRNA against CD44 completely inhibited
the sphere formation of 4T1 cells (Fig. 2l). These results indi-
cated that OPN promotes the sphere formation of 4T1 cells in
a CD44-dependent manner. To determine the OPN receptor in
PMNs, isolated PMNs were cultured with recombinant OPN or
antibodies against OPN receptors in vitro. However, we could
not culture PMNs in vitro due to the short lifespan of PMNs;
almost all PMNs died before the analysis. Alternatively, we
have surveyed OPN receptors on neutrophils in published
works (Table S2) and in the database (Table S3). It is reported
that OPN physiologically interacts with at least nine integrins
and CD44. Judging from Tables S2 and S3, integrin avb1,
avb3, a4b1, a4b7, a5b1, a9b1, and CD44 were candidates of
OPN receptors in PMNs.
Osteopontin activates PMNs during colonization of 4T1
cells. Having elucidated the in vitro role of OPN on 4T1, we
next examined the role of OPN in PMN activation around
tumor cell emboli by injecting 4T1 cells expressing tdTomato
red fluorescent protein into tumor-bearing mice. Here, to show
conclusively that the cells recruited to 4T1 cells were bone
marrow-derived inflammatory cells, we used BALB/c mice
that had been transplanted with the bone marrow of ERK
FRET mice. These bone marrow-transplanted BALB/c mice
were implanted with 4T1 cells at the footpad. Under this
Fig. 2. Requirement of osteopontin (OPN) for sphere formation
in vitro. (a) Conditioned medium of 4T1 cells was subjected to analysis
with a Mouse Cytokine Array 4 Kit (n = 3). (b, c) 4T1 cells expressing
an shRNA against OPN (sh870, sh1057, or sh1102) or a scramble
negative control shRNA (scr) were analyzed by SDS-PAGE and
immunoblotted with anti-OPN (red) and anti-b-tubulin (green) anti-
bodies. b-Tubulin was used for normalization in (c). Bars = SD (n = 3).
(d) 4T1 cell lines expressing shRNAs were subjected to cell growth
assay in vitro. Bars = SD (n = 4). Statistical significance was not
detected by one-way ANOVA (N.S.). (e) Near-infrared fluorescent protein
(iRFP)-labeled 4T1 cells expressing scr or sh870 were cultured in sus-
pension. Phase contrast images are shown. Bar = 200 lm. (f) iRFP
images of 4T1 cell spheres grown in suspension. Bar = 4 mm. (g–i) 4T1
cells with shRNAs were cultured for 24 h in suspension (5 9 105/well).
Spheres larger than 0.1 mm2 were counted (g). Bars = SD (n = 3). Cells
were harvested, dissociated, stained with Trypan blue, and analyzed
with an automated cell counter (h, i). Bars = SD (n = 6). (j) In the first
well, iRFP-labeled sh870-expressing 4T1 cells (5 9 105/well) were cul-
tured. In the second well, iRFP-labeled sh870-expressing 4T1 cells
(2.5 9 105/well) and non-labeled scr-expressing 4T1 cells (2.5 9 105/
well) were cocultured. After 24 h, the number of cell spheres with
iRFP was counted. Bars = SD (n = 3). (k) 4T1 cells were cultured in the
presence of the indicated antibodies at a concentration of 2 lg/mL.
Bars = SD (n = 4). (l) 4T1 cells expressing scr or an shRNA against CD44
(sh308) were cultured in suspension for 24 h. Bars = SD (n = 4). (g–l)
Statistical significance was determined by Student’s t-test. *P < 0.05;
***P < 0.001.
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Fig. 3. Osteopontin (OPN)-dependence of
polymorphonuclear cell (PMN) activation in lungs
of tumor-bearing mice. Bone marrow cells of a
F€orster resonance energy transfer (FRET) mouse for
ERK were transplanted to host BALB/c mice. After
1 month, the mice received 4T1 cells expressing
scramble shRNA (scr) or shRNA against OPN (sh870)
at the footpad. Two weeks after inoculation of 4T1
cells, mice were observed with a two-photon
excitation microscope. (a) To the mouse bearing scr-
expressing 4T1 cells, 6 lg allophycocyanin (APC)-
labeled anti-Ly6G antibody was injected into the
tail vein. Lungs were observed in vivo under a two-
photon excitation microscope. (b, c) In the process
of imaging, the mice were injected i.v. with 4T1
cells expressing either scr (b) or sh870 (c). Upper
panels show PMNs (cyan fluorescent protein [CFP],
shown in green) and tumor cells (tdTomato, shown
in magenta). Lower panels show ERK activity (FRET/
CFP ratio image), with the range of activity
indicated on the left. (d, e) In each time-lapse
image, the activated PMN area showing high ERK
activity, that is FRET/CFP ratio ≥1.3, was measured
and plotted against time (n = 8). Blue and red lines
show the mean value of scr- and sh870-expressing
4T1 cells, respectively. (f) 4T1 cells expressing scr
were inoculated at the footpad (1 9 106/mouse).
Two weeks later, 4T1 cells expressing scr and
tdTomato were injected i.v. into the tumor-bearing
mouse (1 9 105/mouse). Five minutes after
injection, lungs were fixed with 4%
paraformaldehyde in PBS. Frozen sections were
stained with anti-phospho-ERK (pERK) and anti-Gr-1
antibodies. Bar = 20 lm. BMT, bone marrow-
transplanted.
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condition, more than 90% of the FRET biosensor-expressing
cells in the lung were positive for Ly6G/Gr-1, a marker for
PMNs (Fig. 3a). The tumor-bearing BALB/c mice were next
injected with 4T1 cells expressing either scr or sh870 RNA.
When the scr-expressing 4T1 cell emboli were trapped at the
pulmonary capillary, PMNs were recruited to the 4T1 cells
and activated (Figs 3b,d,S5,S6, Movie S2). However, when
OPN-depleted 4T1 cells expressing sh870 were injected into
the BALB/c mice bearing OPN-depleted 4T1 cells at the foot-
pad, recruitment and activation of PMNs were markedly
impaired (Figs 3c,e,S6, Movie S3). Before the i.v. injection of
tumor cells, the numbers of PMNs in the lung were compara-
ble between cells with scr and cells with sh870 (Fig. S7). To
examine whether ERK activation in PMNs is required for
tumor metastasis, we i.v. injected an MEK inhibitor into
tumor-bearing mice after tumor cell injection. As expected,
MEK inhibitor suppressed ERK activation in PMNs and tumor
metastasis (Fig. S8, Movie S4). Immunohistochemistry of
lungs from tumor-bearing mice agreed with the observation by
intravital imaging: ERK activation in PMNs was observed
Fig. 4. Requirement of osteopontin (OPN) for
metastasis in vivo. (a) Blood plasma samples
prepared from a 4T1 tumor-bearing mouse and a
control mouse were subjected to analysis with a
Mouse Cytokine Array 4 Kit. The ratio of protein
expression in the 4T1 tumor-bearing mouse to that
in the control mouse is shown. (b) 4T1 cells
expressing an shRNA against OPN (sh870 or sh1102)
or scramble shRNA (scr) were inoculated into the
footpads of BALB/c mice. The tumor size was
measured at the indicated time. Bars = SD (n = 4).
Statistical significance was not detected by one-way
ANOVA (N.S.). (c) Representative image of the
metastatic foci of near-infrared fluorescent protein
(iRFP)-labeled scr-expressing 4T1 cells. Arrowheads
indicate metastatic foci. (d) Numbers of metastatic
foci of 4T1 cells expressing an shRNA (scr, sh870, or
sh1102) were counted. Bars = SD (n = 7). Statistical
significance was not detected by Student’s t-test.
(e) Sh870-expressing 4T1 cells were injected into
the footpads of BALB/c mice. Two weeks later,
recombinant OPN protein (rOPN; 8.4 lg/mouse) was
injected i.v. into tumor-bearing mice for 5 days
prior to injection of iRFP-labeled sh870-expressing
4T1 cells. The numbers of metastatic foci were
counted. Bars = SD (n = 4). Statistical significance
was not detected by Student’s t-test. (f) The scr-
expressing 4T1 cells were injected into the footpads
of BALB/c mice. Two weeks later, iRFP-labeled scr-
expressing 4T1 cells were injected i.v. One hour
later, DNase I (2000 U/mouse) was also injected i.v.
into tumor-bearing mice. Three days later, the
numbers of metastatic foci were counted. Bars = SD
(n = 4). Statistical significance was not detected by
Student’s t-test. (g) 4T1 cells expressing scr were
inoculated at the footpad (1 9 106/mouse). Two
weeks after the inoculation, the mouse was
injected i.v. with 4T1 cells expressing scr and
tdTomato red fluorescent protein (1 9 105/mouse).
Five hours after the injection, lungs were fixed with
4% paraformaldehyde in PBS. Frozen sections of
fixed lungs were stained with anti-citrullinated
histone H3 (H3Cit) antibody and DAPI. Bar = 20 lm.
(h) Intravital imaging of NETosis in tumor-bearing
mouse. A tumor-bearing mouse was prepared as in
(g). 4T1 cells expressing scr and EGFP were injected
i.v. into the tumor-bearing mouse (1 9 105/mouse).
Five hours after the injection, intravital imaging of
lung was carried out and propidium iodide (PI) was
injected i.v. to visualize extracellular DNA. White
arrowheads indicate characteristic DNA fibers of
NETosis. Bar = 20 lm. *P < 0.05.
© 2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd
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after the injection of tumor cells expressing scr (Figs 3f,S9).
These observations suggested that OPN may be required for
PMN recruitment to the tumor cell emboli.
Osteopontin required for efficient colonization of 4T1 cells.
We observed that OPN was increased 1.7-fold in the blood
plasma of a tumor-bearing mouse (Fig. 4a). To assess the con-
tribution of OPN to lung metastasis over the long term, 4T1
cells expressing shRNAs against OPN or the scr shRNA were
implanted into the footpads of syngeneic BALB/c mice. The
OPN-depleted 4T1 cells formed a local tumor mass as effi-
ciently as did the scr shRNA-expressing control 4T1 cells
(Fig. 4b). However, the numbers of metastatic colonies were
significantly reduced in mice inoculated with OPN-depleted
4T1 cells compared to those in the mice inoculated with the
scr shRNA-expressing 4T1 cells (Fig. 4c,d). Notably, injection
of rOPN induced ERK activation in PMNs (Fig. S10, Movie
S5) and co-injection of rOPN significantly facilitated the colo-
nization of OPN-depleted 4T1 cells in the lung (Fig. 4e), indi-
cating that OPN functions in a paracrine manner.
Because OPN was required for PMN activation around the
tumor emboli (Fig. 3), we reasoned that OPN-mediated acti-
vation of PMNs may play roles in the colonization of 4T1
cells in the lung. Because ERK activation induces NETosis,
we speculated that a NET may contribute to the colonization
of 4T1 cells in the lung. To test this hypothesis, DNase I, an
inhibitor of NET, was co-injected with 4T1 cells. As
expected, DNase I significantly inhibited the colonization of
4T1 cells in the lung (Fig. 4f). To support these observations,
extracellular DNA that is characteristic of NETosis was also
detected by immunohistochemistry and intravital imaging
(Fig. 4g,h). These results suggested that OPN-mediated ERK
activation in PMNs facilitates tumor colonization by means
of NETosis.
Discussion
Here, by using a vacuum-assisted stabilizer, we succeeded in
the visualization of PMNs infiltrating tumor-burdened mouse
lungs. The use of FRET mice for ERK further allowed us to
observe PMN activation around tumor emboli in the lung.
Phagocytosis of the fragmented cell bodies of cancer cells has
already been live-imaged in the lung,(15) but additional infor-
mation on the activities of signaling molecules will pave the
way for the association of molecular activities with cellular
function.
The expression level of OPN in the blood plasma or tissues
correlates with poor prognosis in various malignant diseases,
including breast cancers.(28) In in vitro and in vivo models,
OPN has been shown to play critical roles in tumor progres-
sion and metastasis by interacting with multiple cell surface
receptors, including integrins and CD44.(8,9) Ironically, how-
ever, such pleiotropic functions obscure the principal effects of
OPN, particularly in vivo. For example, it is not clear whether
the increase in serum OPN is sufficient for OPN to affect
remote organs. In our 4T1 cell model, the increase in OPN in
serum was less than twofold that in the control (Fig. 4a).
Because we examined only a single tumor-bearing mouse, we
cannot speculate at length on this observation; however, it does
suggest that the increased serum OPN level may not have bio-
logical meaning except as a marker of tumor growth. In fact,
knockdown of OPN did not affect PMN accumulation in the
lung (Figs 3c,S7) or hepatosplenomegaly (data not shown). In
consideration of these findings, we suggest that, at least in the
4T1 tumor model, OPN may function in a paracrine manner.
The paracrine function of OPN includes sphere formation
in vitro (Fig. 2). The requirement of OPN for anchorage-inde-
pendent cell growth and protection from anoikis has been
reported in human breast cancer cells and murine epidermal
cells.(29,30) We have also found that OPN is required for cell
growth in suspension culture. However, considering the period
required for tumor cells to move from the primary tumor site
to the lung, it remains unknown whether the prevention of
anoikis in the blood affects the overall efficiency of lung
metastasis in vivo.
In this regard, OPN may play a more important role in
recruiting PMNs to the 4T1 tumor emboli at the pulmonary
capillary. The PMNs around 4T1 tumor emboli were Ly6G/
Gr-1-positive, suggesting that these PMNs were granulocytic
MDSCs (Fig. 3a). Therefore, the PMNs may prevent cytotoxic
or helper T cells from recognizing 4T1 cells and thereby pro-
mote the colonization of metastatic 4T1 cells. Alternatively,
because PMNs are activated by binding to 4T1 cells, they may
contribute to the holding of 4T1 cells by NET. Indeed, it has
already been reported that NET contributes to the progression
of many tumors.(31,32)
Because ERK activation mediates the NETosis induced by
phorbol-12-myristate-13-acetate, calcium pyrophosphate dehy-
drate, or Leishmania,(33–35) the robust ERK activation around
4T1 cells in the lungs strongly argues for the occurrence of
NETosis. In fact, released DNA that is characteristic of NETo-
sis was confirmed by immunohistochemistry and intravital
imaging of lungs (Fig. 4g,h). The reduction of lung metastasis
by DNase I treatment further supports the idea that ERK-
mediated NETosis makes a major contribution to the lung
metastasis of 4T1 cells (Fig. 4f).
In conclusion, the present work has shown that the intravital
imaging of FRET mice is a powerful method to examine the
interaction between host and tumor cells. This approach could
also be used to examine the effect of antitumor therapy in
environments closely resembling those in human patients or
using patient-derived xenografts.
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Fig. S1. Representative two-photon image of mouse lung.
Fig. S2. Quantification of area of polymorphonuclear cells (PMNs) and activated PMNs in Figure 1(f).
Fig. S3. Polymorphonuclear cell (PMN) accumulation, ERK phosphorylation, and osteopontin (OPN) deposition in lungs after tumor inoculation.
Fig. S4. Cytokines detected from conditioned medium of 4T1 cell culture.
Fig. S5. Quantification of ERK activity from the proximity of tumor emboli to the distant area.
Fig. S6. Statistical analysis of osteopontin (OPN)-dependent polymorphonuclear cell (PMN) activation in Figure 3.
Fig. S7. Polymorphonuclear cell (PMN) areas in the lungs of mice inoculated with scramble shRNA (scr)-expressing tumor cells or sh870-expres-
sing tumor cells.
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Fig. S8. ERK activation in polymorphonuclear cells (PMN) is required for osteopontin (OPN)-mediated metastasis.
Fig. S9. ERK activation in polymorphonuclear cells (PMNs) after i.v. injection of tumor cells.
Fig. S10. Osteopontin (OPN)-mediated ERK activation in polymorphonuclear cells (PMNs).
Table S1. Nucleotides inserted into pLKO.1-TRC for depleting murine osteopontin (OPN) and murine CD44.
Table S2. Osteopontin (OPN) receptors in polymorphonuclear cells (PMNs) reported in published works.
Table S3. Osteopontin (OPN) receptors in polymorphonuclear cells (PMNs) in the database.
Movie S1. Movie corresponding to Figure 1(f). Bone marrow cells of a F€orster resonance energy transfer (FRET) mouse for ERK were transferred
to a recipient BALB/c mouse. One month after bone marrow transplantation, 4T1 cells were inoculated at the footpad. The lung was observed on
the day of tumor cell inoculation (day 0) and on day 7. Yellow fluorescent protein images (left) and FRET/cyan fluorescent protein images for
ERK activity (right) are shown. Of note, ERK activation is observed in some polymorphonuclear cells (arrowheads).
Movie S2. Movie corresponding to Figure 3(b). Bone marrow cells of a F€orster resonance energy transfer (FRET) mouse for ERK were trans-
planted to host BALB/c mice. After 1 month, the mice received 4T1 cells expressing scramble shRNA (scr) at the footpad. Two weeks after inoc-
ulation of 4T1 cells, the mice were injected i.v. with tdTomato-labeled scr-expressing 4T1 cells and observed with a two-photon excitation
microscope. Upper panels show polymorphonuclear cells (cyan fluorescent protein [CFP], shown in green) and tumor cells (tdTomato, shown in
magenta). Lower panels show ERK activity (FRET/CFP ratio image), with the Intensity Modulated Display (IMD) mode.
Movie S3. Movie corresponding to Figure 3(c). Bone marrow cells of a F€orster resonance energy transfer (FRET) mouse for ERK were trans-
planted to host BALB/c mice. After 1 month, the mice received 4T1 cells expressing an shRNA against osteopontin (sh870) at the footpad. Two
weeks after the inoculation of 4T1 cells, the mice were injected i.v. with tdTomato-labeled sh870-expressing 4T1 cells and observed with a two-
photon excitation microscope. Lower panels show ERK activity (FRET/cyan fluorescent protein ratio image), with Intensity Modulated Display
(IMD) mode.
Movie S4. Movie corresponding to Figure S8(a). Bone marrow cells of a F€orster resonance energy transfer (FRET) mouse for ERK were trans-
planted to a host BALB/c mouse. After 1 month, the mouse received 4T1 cells expressing scramble shRNA (scr) at the footpad. Two weeks after
inoculation of 4T1 cells, mice were observed with a two-photon excitation microscope. The tumor-bearing mouse was injected i.v. with 4T1 cells
expressing scr and tdTomato red fluorescent protein at time zero. After 13 min, MEK inhibitor (PD0325901, 200 lg in 200 lL PBS) was injected
i.v. with 3 lL Qtracker 655 as a vasculature marker. Right panels show polymorphonuclear cells (cyan fluorescent protein [CFP], shown in green)
and tumor cells (tdTomato, shown in magenta). Left panels show ERK activity (FRET/CFP ratio image range 1.0–2.0).
Movie S5. Movie corresponding to Figure S10. Bone marrow cells of a F€orster resonance energy transfer (FRET) mouse for ERK were trans-
planted to host BALB/c mouse (6 9 106/mouse). After 1 month, the mouse received 4T1 cells expressing shRNA against osteopontin (OPN)
(sh870) at the footpad (1 9 106/mouse). Two weeks later, the mouse was observed with a two-photon excitation microscope. Recombinant OPN
protein (rOPN, 8.4 lg/mouse) and vasculature marker Qtracker 655 (0.03 lM) were injected i.v. into the tumor-bearing mouse at time zero (right
image). Arrowheads indicate aggregations of polymorphonuclear cells with high ERK activity (left image).
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